Aoife M. Brennan's most recent trade in Climb Bio Inc. was a trade of 68,750 Restricted Stock Units done . Disclosure was reported to the exchange on June 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Climb Bio Inc | Aoife M. Brennan | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2025 | 68,750 | 206,250 | - | - | Restricted Stock Units | |
| Climb Bio Inc | Aoife M. Brennan | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2025 | 68,750 | 68,750 | - | - | Common Stock | |
| Climb Bio Inc | Aoife M. Brennan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.22 per share. | 27 Jun 2025 | 20,618 | 48,132 | - | 1.2 | 25,154 | Common Stock |
| Xilio Therapeutics Inc | Aoife M. Brennan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 31,000 | 31,000 | - | - | Stock Option (right to buy) | |
| Climb Bio Inc | Aoife M. Brennan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2025 | 1,150,000 | 1,150,000 | - | - | Stock Option (Right to Buy) | |
| Climb Bio Inc | Aoife M. Brennan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 550,000 | 550,000 | - | - | Stock Option (Right to Buy) | |
| Climb Bio Inc | Aoife M. Brennan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 275,000 | 275,000 | - | - | Restricted Stock Units | |
| Xilio Therapeutics Inc | Aoife M. Brennan | Director | 13 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | ||
| FibroGen Inc | Aoife M. Brennan | Director | 05 Jun 2024 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | ||
| FibroGen Inc | Aoife M. Brennan | Director | 07 Jun 2023 | 12,666 | 12,666 | - | - | Stock Option (Right to Buy) | ||
| FibroGen Inc | Aoife M. Brennan | Director | 07 Jun 2023 | 8,289 | 32,680 (0%) | 0% | 0 | Common Stock | ||
| FibroGen Inc | Aoife M. Brennan | Director | 07 Jun 2023 | 2,739 | 27,947 (0%) | 0% | 17.5 | 47,987 | Common Stock | |
| FibroGen Inc | Aoife M. Brennan | Director | 07 Jun 2023 | 1,994 | 30,686 (0%) | 0% | 16.7 | 33,380 | Common Stock | |
| Synlogic Inc | Aoife M. Brennan | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 0.58 per share. | 03 Apr 2023 | 19,042 | 256,301 (0%) | 0% | 0.6 | 10,964 | Common Stock |
| FibroGen Inc | Aoife M. Brennan | Director | 16 Jun 2022 | 25,684 | 25,684 | - | - | Stock Option (Right to Buy) | ||
| FibroGen Inc | Aoife M. Brennan | Director | 16 Jun 2022 | 15,777 | 24,391 (0%) | 0% | 0 | Common Stock | ||
| Synlogic Inc | Aoife M. Brennan | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 2.45 per share. | 04 Apr 2022 | 8,894 | 275,343 (0%) | 0% | 2.4 | 21,754 | Common Stock |
| Synlogic Inc | Aoife M. Brennan | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 434,160 | 434,160 | - | - | Stock Option (right to buy) | |
| Synlogic Inc | Aoife M. Brennan | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 106,920 | 284,237 (0%) | 0% | 0 | Common Stock | |
| FibroGen Inc | Aoife M. Brennan | Director | 26 May 2021 | 7,800 | 7,800 | - | - | Stock Option (Right to Buy) | ||
| FibroGen Inc | Aoife M. Brennan | Director | 26 May 2021 | 4,700 | 8,614 (0%) | 0% | 0 | Common Stock | ||
| Synlogic Inc | Aoife M. Brennan | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2021 | 285,000 | 285,000 | - | - | Stock Option (right to buy) | |
| Synlogic Inc | Aoife M. Brennan | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2021 | 71,250 | 177,317 (0%) | 0% | 0 | Common Stock |